The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has ...

Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers federal public health agencies. Senior Food and Drug Administration leaders are planning for ...

FDA's former top official warns of "giving people false hope" after RFK Jr.'s autism claims Food and Drug Administration officials have told some scientists and inspections staff that their ...

Food and Drug Administration Commissioner Marty Makary (pictured) speaks as he joins US President Donald Trump in the Oval Office at the White House on May 5, 2025 in Washington, DC.© Anna ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...

June 18 (UPI) -- The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease. The drug's scientific ...

Earlier this week, two new leaders of the US Food and Drug Administration published a list of priorities for the agency. Both Marty Makary and Vinay Prasad are controversial figures in the science ...

News Business Wire U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer ...

DR. SARA BRENNER, DEPUTY COMMISSIONER, FOOD AND DRUG ADMINISTRATION: Here we go. So first we will go with George Tidmarch, MD, PhD, our adjunct professor of pediatrics neonatology from Stanford.

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and other drugs.

Food and Drug Administration staff cuts may hinder US biomedical innovation by Former Rep. John T. Doolittle (R-Calif.), opinion contributor - 06/22/25 12:00 PM ET ...